Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product

  2.3.2 Market Size By Test Type

  2.3.3 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material & Biochemical Reagent Suppliers

         3.4.2 Diagnostic Assay & Test Kit Manufacturers

         3.4.3 Instrumentation & Analytical Equipment Providers

         3.4.4 Distribution Networks & End-Use Healthcare Facilities

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

 4.1 Pricing Analysis & Reimbursement Landscape

     4.1.1 Overview

     4.1.2 Pricing Analysis by Product, 2022–2035

     4.1.3 Test Type Pricing Benchmarking (Rapid Tests vs Viral Load vs CD4 Count), 2024

     4.1.4 Reimbursement & Government Funding Impact on HIV Diagnostics Access

   4.2 Technology Adoption & Innovation Trends

     4.2.1 Overview

     4.2.2 Transition from ELISA to Fourth-Generation Immunoassays

     4.2.3 Growth of Molecular Viral Load Testing Platforms

     4.2.4 Expansion of Point-of-Care & Rapid Diagnostic Technologies

     4.2.5 AI Integration in Diagnostic Interpretation & Reporting

   4.3 Test Type Demand Analysis

     4.3.1 Overview

     4.3.2 Antibody & Screening Test Adoption Trends

     4.3.3 Viral Load Testing Demand Growth

     4.3.4 CD4 Count Testing Utilization Trends

     4.3.5 Early Infant Diagnosis & Confirmatory Testing Trends

     4.3.6 Rapid / Self-Testing Market Expansion

   4.4 End-User Adoption Trends

     4.4.1 Overview

     4.4.2 Diagnostic Laboratories & Hospital-Based Testing Demand

     4.4.3 Home Care & Self-Testing Growth Trends

     4.4.4 Blood Bank Screening Requirements

     4.4.5 Academic & Research Institute Applications

   4.5 Regional Market & Epidemiological Trends

     4.5.1 Overview

     4.5.2 HIV Prevalence-Driven Testing Demand

     4.5.3 North America & Europe Diagnostic Infrastructure Trends

     4.5.4 Asia Pacific & Africa Testing Expansion Programs

     4.5.5 Government Screening & Public Health Initiatives

5. HIV Diagnostics Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Consumables/Assay Kits & Reagents

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Instruments

 5.4 Software & Services

6. HIV Diagnostics Market Segmental Analysis & Forecast, By Test Type, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Antibody Tests/Screening

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Viral Load Tests

 6.4 CD4 Count Tests

 6.5 Early Infant Diagnosis Tests

 6.6 Confirmatory Tests/Western Blot & ELISA

 6.7 Rapid/Point-of-Care Tests

7. HIV Diagnostics Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Diagnostic Laboratories

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Hospitals & Clinics

 7.4 Home Care Settings/Self-Testing

 7.5 Blood Banks

 7.6 Academic & Research Institutes

8. HIV Diagnostics Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 HIV Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.2.3 HIV Diagnostics Market Size & Forecast, By Test Type, 2022–2035

 8.2.4 HIV Diagnostics Market Size & Forecast, By End User, 2022–2035

 8.2.5 HIV Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 HIV Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.3.3 HIV Diagnostics Market Size & Forecast, By Test Type, 2022–2035

 8.3.4 HIV Diagnostics Market Size & Forecast, By End User, 2022–2035

 8.3.5 HIV Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 HIV Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.4.3 HIV Diagnostics Market Size & Forecast, By Test Type, 2022–2035

 8.4.4 HIV Diagnostics Market Size & Forecast, By End User, 2022–2035

 8.4.5 HIV Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 HIV Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.5.3 HIV Diagnostics Market Size & Forecast, By Test Type, 2022–2035

 8.5.4 HIV Diagnostics Market Size & Forecast, By End User, 2022–2035

 8.5.5 HIV Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 HIV Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.6.3 HIV Diagnostics Market Size & Forecast, By Test Type, 2022–2035

 8.6.4 HIV Diagnostics Market Size & Forecast, By End User, 2022–2035

 8.6.5 HIV Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 South Africa

  8.6.5.5 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022–2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Test Type Benchmarking

  9.4.1 Product/Service Specifications & Features By Key Players

  9.4.2 Product/Service Heatmap By Key Players

  9.4.3 Test Type Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

 9.6.1 Abbott Laboratories

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Product/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

 9.6.2 F. Hoffmann-La Roche Ltd. (Roche Diagnostics)

    9.6.3 Siemens Healthineers AG

    9.6.4 Danaher Corporation

    9.6.5 Thermo Fisher Scientific Inc.

    9.6.6 bioMérieux SA

    9.6.7 Becton, Dickinson and Company

    9.6.8 Hologic Inc.

    9.6.9 Qiagen N.V.

    9.6.10 Bio-Rad Laboratories Inc.

    9.6.11 OraSure Technologies Inc.

    9.6.12 Grifols S.A.

    9.6.13 Trinity Biotech plc

    9.6.14 Chembio Diagnostics (BioSynex)

    9.6.15 Wondfo Biotech Co., Ltd.

    9.6.16 Getein Biotech Inc.

    9.6.17 Meril Diagnostics Pvt. Ltd.

    9.6.18 BioLytical Laboratories Inc.

    9.6.19 Sysmex Corporation

    9.6.20 AccuBioTech Co., Ltd.

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures